This article discusses the evidence for using a combination of SGLT2 inhibitors & DPP-4 inhibitors in addition to standard care for the management of type 2 diabetes and its complications.
Written by Prof Merlin Thomas, MBChB, PhD, FRACP
Prof Merlin Thomas is a Professor of Medicine at Monash University, Melbourne. Professor Thomas is both a physician and a research scientist. He has published over 300 articles in many of the world’s leading medical journals, as well as several books including The Longevity List and Fast Living, Slow Ageing. He is internationally recognised as a speaker, opinion-leader, teacher and medical storyteller. His research focuses on discovering new ways to prevent and treat the complications of diabetes.